Cerebrovascular Disorders

• 

  Subject Areas on Research

  • A controlled study of MRI signal hyperintensities in older depressed patients with and without hypertension. 
  • A dose escalation study of ORG 10172 (low molecular weight heparinoid) in stroke. 
  • A follow-up survey of clinical practices for the use of heparin, warfarin, and aspirin. 
  • A linear models application of competing risks to multiple causes of death. 
  • A mathematical model of the physiological dynamics of aging and correlated mortality selection: II. Application to the Duke Longitudinal Study. 
  • A multiple cause of death analysis of hypertension-related mortality in North Carolina, 1968-1977. 
  • A practical approach to CT angiography of the neck and brain. 
  • A randomized, double-blind, placebo-controlled ascending dose tolerance study of 619C89 in acute stroke. 
  • A randomized, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke. 
  • ACR Appropriateness Criteria® Cerebrovascular Disease. 
  • APOE/TOMM40 genetic loci, white matter hyperintensities, and cerebral microbleeds. 
  • Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic stroke: effect of modifier codes. 
  • Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial. 
  • Acute febrile cerebrovasculitis. A non-spotted fever group rickettsial disease. 
  • Acute stroke: evaluation with serial proton MR spectroscopic imaging. 
  • Adapting human postural reflexes following localized cerebrovascular lesion: analysis of bilateral long latency responses. 
  • Advances in primary stroke prevention. 
  • Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. 
  • Agalsidase-beta therapy for advanced Fabry disease: a randomized trial. 
  • Aggressive therapy of acute MI in the elderly. 
  • Alpers' syndrome presenting with seizures and multiple stroke-like episodes in a 17-year-old male. 
  • American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. 
  • Amphetamine-facilitated poststroke recovery. 
  • An analysis of the heterogeneity of U.S. nursing home patients. 
  • An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. 
  • Anesthesia for interventional neuroradiology. 
  • Angiotensin converting enzyme and genetic hypertension: cloning of rat cDNAs and characterization of the enzyme. 
  • Ankle-brachial index, cognitive impairment and cerebrovascular disease in a Chinese population. 
  • Anticardiolipin antibodies in an unselected stroke population. 
  • Antiphospholipid antibodies: findings at arteriography. 
  • Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis. 
  • Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events. 
  • ApoE genotype and survival from intracerebral haemorrhage. 
  • Apolipoprotein E genotype and subcortical vascular lesions in older depressed patients and control subjects. 
  • Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more. 
  • Apolipoprotein E4 allele frequency, ischemic cerebrovascular disease, and Alzheimer's disease. 
  • Aspiration after stroke: lesion analysis by brain MRI. 
  • Aspiration following stroke: clinical correlates and outcome. 
  • Aspiration in bilateral stroke patients. 
  • Aspiration in bilateral stroke patients: a validation study. 
  • Assessing uncertainty in cost-effectiveness analyses: application to a complex decision model. 
  • Asymptomatic carotid artery stenosis and stroke in patients undergoing cardiopulmonary bypass. 
  • Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. 
  • Atrial fibrillation: conventional wisdom reappraised. 
  • Atrial septal aneurysm: association with cerebrovascular and peripheral embolic events. 
  • Attained educational level and incident atherothrombotic events in low- and middle-income compared with high-income countries. 
  • Background factors and clinical symptoms of major depression with silent cerebral infarction. 
  • Barbiturate protection and cardiac surgery: a different result. 
  • Baseline NIH Stroke Scale score strongly predicts outcome after stroke: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). 
  • Blood flow imaging of a posterior circulation stroke. Use of technetium Tc 99m hexamethylpropyleneamine oxime and single photon emission computed tomography. 
  • Bone marrow transplantation for sickle cell disease. 
  • Brain anatomic effects of electroconvulsive therapy. A prospective magnetic resonance imaging study. 
  • C-reactive protein and outcome after ischemic stroke. 
  • CVD mortality, 1968-1978: observations and implications. 
  • Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry). 
  • Cause specific mortality patterns among the oldest old: multiple cause of death trends 1968 to 1980. 
  • Cellular abnormalities linked to endoplasmic reticulum dysfunction in cerebrovascular disease--therapeutic potential. 
  • Cerebral magnetic resonance findings in asymptomatic patients after atrial fibrillation catheter ablation: cause for alarm or further study? 
  • Cerebral vasculitis. 
  • Cerebrovascular disease and depression symptoms in the cardiovascular health study. 
  • Cerebrovascular disease and evolution of depressive symptoms in the cardiovascular health study. 
  • Cerebrovascular risk factors and cerebral hyperintensities among middle-aged and older adults with major depression. 
  • Cerebrovascular risk factors, vascular disease, and neuropsychological outcomes in adults with major depression. 
  • Cigarette smoke modulates vascular smooth muscle phenotype: implications for carotid and cerebrovascular disease. 
  • Circadian variation in ischemic stroke subtypes. 
  • Clinical Crossroads: a 36-year-old woman recuperating from stroke. 
  • Clinical Crossroads: a 36-year-old woman recuperating from stroke. 
  • Clinical and angiographic correlates of short- and long-term mortality in patients undergoing coronary artery bypass grafting. 
  • Clinical assessment of MR of the brain in nonsurgical inpatients. 
  • Clinical pharmacology of CNS 1102 in man. 
  • Clinical practices, complications, and mortality in neurological patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension registry. 
  • Clinical preventive practice. 
  • Clinical stroke trials: guarding against bias. 
  • Clonidine impairs recovery of beam-walking after a sensorimotor cortex lesion in the rat. 
  • Cognitive dysfunction after cardiac surgery: revisiting etiology. 
  • Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed. 
  • Common drugs may influence motor recovery after stroke. The Sygen In Acute Stroke Study Investigators. 
  • Comorbidity of five chronic health conditions in elderly community residents: determinants and impact on mortality. 
  • Comparison of neurological scales and scoring systems for acute stroke prognosis. 
  • Comparison of slow oscillating versus fast balloon inflation strategies for coronary angioplasty. 
  • Comparison of the responsiveness of the Barthel Index and the motor component of the Functional Independence Measure in stroke: the impact of using different methods for measuring responsiveness. 
  • Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators. 
  • Cortical cerebral microinfarcts on 3T MRI: A novel marker of cerebrovascular disease. 
  • Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. 
  • Costs and outcomes of hip fracture and stroke, 1984 to 1994. 
  • Cyclosporin A-related cerebral vasculopathy. 
  • Decision making in the face of uncertainty: the case of carotid endarterectomy. 
  • Deconstructing racial differences: the effects of quality of education and cerebrovascular risk factors. 
  • Depressed platelet status in an elderly patient with hemorrhagic stroke after thrombolysis for acute myocardial infarction. 
  • Depressed platelet status in an elderly patient with hemorrhagic stroke after thrombolysis for acute myocardial infarction. GUSTO-III Investigators. 
  • Depression as a contributing factor in cerebrovascular disease. 
  • Depressive symptomatology and hypertension-associated morbidity and mortality in older adults. 
  • Design of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). 
  • Determining the incidence of different subtypes of stroke: results from the Perth Community Stroke Study, 1989-1990. 
  • Developmental and lesion effects in brain activation during sentence comprehension and mental rotation. 
  • Diagnosis of intracranial vasculitis: a multi-disciplinary approach. 
  • Differences in Short- and Long-Term Outcomes Among Older Patients With ST-Elevation Versus Non-ST-Elevation Myocardial Infarction With Angiographically Proven Coronary Artery Disease. 
  • Early recurrent ischemic stroke. A case-control study. 
  • Economic implications of the prophylactic use of intraaortic balloon counterpulsation in the setting of acute myocardial infarction. The Randomized IABP Study Group. Intraaortic Balloon Pump. 
  • Effect of niacin on atherosclerotic cardiovascular disease. 
  • Effect of niacin on atherosclerotic cardiovascular disease. 
  • Effects of admission to a teaching hospital on the cost and quality of care for Medicare beneficiaries. 
  • Effects of dependency among causes of death for cause elimination life table strategies. 
  • Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Study. 
  • Emergency management of the patient with seizures. 1. Classification and treatment system, common seizure disorders. 
  • Empirical estimation of life expectancy from large clinical trials: use of left-truncated, right-censored survival analysis methodology. 
  • Endarterectomy in carotid artery disease. A decision analysis. 
  • Endothelial dysfunction in cerebral microcirculation during hypothermic cardiopulmonary bypass in newborn lambs. 
  • Endovascular stroke intervention in young patients with large vessel occlusions. 
  • Epsilon-aminocaproic acid administration and stroke following coronary artery bypass graft surgery. 
  • Establishing diagnostic criteria for vascular depression. 
  • Estimates of U.S. multiple cause life tables. 
  • Evaluation of the Heart and Stroke Foundation of Canada Research Scholarship Program: research productivity and impact. 
  • Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. 
  • Evidence-based medicine and stroke. 
  • Evolving role of biomarkers in acute cerebrovascular disease. 
  • Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study. 
  • Food group intake and brain lesions in late-life vascular depression. 
  • Full-dose aprotinin use in coronary artery bypass graft surgery: an analysis of perioperative pharmacotherapy and patient outcomes. 
  • Functional organization of activation patterns in children: whole brain fMRI imaging during three different cognitive tasks. 
  • Ganglioside GM1 in acute ischemic stroke. The SASS Trial. 
  • Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. 
  • Geographic differences in mortality from stroke in North Caroline. 1. Analysis of death certificates. 
  • Geriatric depression and cognitive impairment. 
  • Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the Ad Hoc Committee, American Heart Association. 
  • Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the ad hoc Committee, American Heart Association. 
  • Guidelines for carotid endarterectomy: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. 
  • Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. 
  • Guidelines on the use of thrombolytic agents in stroke. 
  • Health status of individuals with mild stroke. 
  • High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillance. 
  • Hospitalization and case-fatality rates for stroke in Canada from 1982 through 1991. The Canadian Collaborative Study Group of Stroke Hospitalizations. 
  • Hospitalization and case-fatality rates for subarachnoid hemorrhage in Canada from 1982 through 1991. The Canadian Collaborative Study Group of Stroke Hospitalizations. 
  • How should a patient presenting with unstable angina and a recent stroke be managed? 
  • Hydroxyurea: an alternative to transfusion therapy for stroke in sickle cell anemia. 
  • Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients. 
  • Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. 
  • Imaging and genetics advances in understanding geriatric depression. 
  • Imaging of Cerebrovascular Disease in Pregnancy and the Puerperium. 
  • Impact of extracardiac vascular disease on vein graft failure and outcomes after coronary artery bypass surgery. 
  • Impact of social support on outcome in first stroke. 
  • Inaccuracy of the ICD-9-CM in identifying the diagnosis of ischemic cerebrovascular disease. 
  • Inaccuracy of the International Classification of Diseases (ICD-9-CM) in identifying the diagnosis of ischemic cerebrovascular disease. 
  • Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1: Population-Based Approach. 
  • Influence of projected complication rates on estimated appropriate use rates for carotid endarterectomy. Appropriateness Project Investigators. Academic Medical Center Consortium. 
  • Inpatient costs of specific cerebrovascular events at five academic medical centers. 
  • Inpatient costs, length of stay, and mortality for cerebrovascular events in community hospitals. 
  • Insights derived from the thrombolysis and angioplasty in myocardial infarction (TAMI) trials. 
  • Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials. The TOAST Investigators. 
  • Interrater reliability of the NIH stroke scale. 
  • Intracranial fibromuscular dysplasia in a 5-year-old child. 
  • Is age-related macular degeneration a manifestation of systemic disease? New prospects for early intervention and treatment. 
  • John Henryism and the health of African-Americans. 
  • Knowledge of risk among patients at increased risk for stroke. 
  • Large-dose infusions of heparinoid ORG 10172 in ischemic stroke. 
  • Leading Causes of Death among Asian American Subgroups (2003-2011). 
  • Left ventricular ejection fraction may not be useful as an end point of thrombolytic therapy comparative trials. 
  • Licorice-associated reversible cerebral vasoconstriction with PRES. 
  • Lipids and stroke: a paradox resolved. 
  • Longitudinal magnetic resonance imaging vascular changes, apolipoprotein E genotype, and development of dementia in the neurocognitive outcomes of depression in the elderly study. 
  • MCA flow asymmetry is a marker for cerebrovascular disease. 
  • MR arteriography of intracranial circulation. 
  • MRI lesion severity and mortality in geriatric depression. 
  • MRI signal hyperintensities in geriatric depression. 
  • MRI-defined vascular depression: a review of the construct. 
  • Management of Adult Stroke Rehabilitation Care: a clinical practice guideline. 
  • Measurement of motor recovery after stroke. Outcome assessment and sample size requirements. 
  • Medical comorbidity in bipolar disorder: re-prioritizing unmet needs. 
  • Medical treatment for stroke prevention. 
  • Meningitis, vasculitis, and cerebritis caused by CNS histoplasmosis: radiologic-pathologic correlation. 
  • Microsurgical resection of vestibular schwannomas: complication avoidance. 
  • Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. 
  • Mood disorders in the medically ill: scientific review and recommendations. 
  • Mortality model based on delays in progression of chronic diseases: alternative to cause elimination model. 
  • Mortality of the chronically impaired. 
  • Mr. Piano Man: reflections on the life of physician, scientist, and humanitarian, William L. Young, MD (1954-2013). 
  • Multi-stage segmentation of white matter hyperintensity, cortical and lacunar infarcts. 
  • Multicenter preoperative stroke risk index for patients undergoing coronary artery bypass graft surgery. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. 
  • Multicenter review of preoperative risk factors for carotid endarterectomy in patients with ipsilateral symptoms. 
  • Multicenter review of preoperative risk factors for endarterectomy for asymptomatic carotid artery stenosis. 
  • Multiparametric imaging of blood flow and metabolism after middle cerebral artery occlusion in cats. 
  • Myocardial infarction and stroke. 
  • National trends in stroke-related mortality: a comparison of multiple cause mortality data with survey and other health data. 
  • Natural history of cerebral complications of coronary artery bypass graft surgery. 
  • Neuroimaging in late-life depression. 
  • Neurologic complications after allogeneic marrow transplantation for sickle cell anemia. 
  • Neurologic manifestations of gastrointestinal disease. 
  • Neurologic outcomes after coronary artery bypass grafting with and without cardiopulmonary bypass. 
  • Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary Arteries. 
  • Neurovascular coupling during spreading depolarizations. 
  • Nocturnal blood pressure, morning blood pressure surge, and cerebrovascular events. 
  • Nontraumatic neurologic emergencies: imaging findings and diagnostic pitfalls. 
  • North Carolina stroke prevention and treatment facilities survey: rtPA therapy for acute stroke. 
  • Novel polymorphism in the A4 region of the amyloid precursor protein gene in a patient without Alzheimer's disease. 
  • Occlusion of large cerebral vessels in sickle-cell anemia. 
  • Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1. 
  • Orbital phlebography in the study of cavernous sinus disease. 
  • Overview of diffusion imaging. 
  • Patient preferences for stroke outcomes. 
  • Percutaneous right and left heart catheterization in children. Experience with 1,000 patients. 
  • Perioperative morbidity and mortality in combined vs. staged approaches to carotid and coronary revascularization. 
  • Peripheral vascular disease. Diagnosing and treating the 3 most common peripheral vasculopathies. 
  • Peroneal palsy in stroke patients. 
  • Pharmacokinetics of 619C89, a novel neuronal sodium channel inhibitor, in acute stroke patients after loading and discrete maintenance infusions. 
  • Pharmacology of recovery after stroke. 
  • Physician prescribing patterns following hospital admission for ischemic cerebrovascular disease. 
  • Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction. 
  • Population impact of mortality reduction: the effects of elimination of major causes of death on the 'saved' population. 
  • Post-stroke depression in the elderly. 
  • Poststroke pruritus. 
  • Potential effects of common drugs on stroke recovery. 
  • Predicting and preventing adverse neurologic outcomes with cardiac surgery. 
  • Predicting complications of carotid endarterectomy. 
  • Predicting the cost of illness: a comparison of alternative models applied to stroke. 
  • Predicting the cost of illness: a comparison of alternative models applied to stroke. 
  • Predictors of length of hospital stay in elderly hip fracture patients. 
  • Preoperative risk factors for carotid endarterectomy. 
  • Presenting pulse pressure predicts thrombolytic therapy-related intracranial hemorrhage. Thrombolytic Predictive Instrument (TPI) Project results. 
  • Prevalence of symptomatic diastolic heart failure in patients hospitalized with cerebral or peripheral vascular disease. 
  • Preventing ischemic stroke in patients with prior stroke and transient ischemic attack : a statement for healthcare professionals from the Stroke Council of the American Heart Association. 
  • Primary care physician-reported secondary and tertiary stroke prevention practices. A comparison between the United States and the United Kingdom. 
  • Primary prevention of stroke. 
  • Primary prevention of stroke. 
  • Primum non nocere: antithombotics after intracerebral hemorrhage? 
  • Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. 
  • Priorities for comparative effectiveness reviews in cardiovascular disease. 
  • Prognostication of recovery following stroke using the comparison of CT and technetium-99m HM-PAO SPECT. 
  • Progression of impairment in patients with vascular cognitive impairment without dementia. 
  • Proton magnetic resonance spectroscopy and gadolinium-DTPA perfusion imaging of asymptomatic MRI white matter lesions. 
  • Pulse pressure and risk of adverse outcome in coronary bypass surgery. 
  • Racial differences in the utilization of inpatient rehabilitation services among elderly stroke patients. 
  • Racial variations in ischemic stroke-related physical and functional impairments. 
  • Radiologic intervention in the acute stroke patient. 
  • Radionuclide emission computed tomography of the head with 99mCc and a scintillation camera. 
  • Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease. 
  • Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry. 
  • Re: Total prostatoseminal vesiculectomy in the treatment of debilitating perineal pain. 
  • Recent advances in imaging of cerebrovascular disease. 
  • Recommended guidelines for reviewing, reporting, and conducting research on in-hospital resuscitation: the in-hospital 'Utstein style'. A statement for healthcare professionals from the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, the Australian Resuscitation Council, and the Resuscitation Councils of Southern Africa. 
  • Recurrent transient ischemic attacks and stroke associated with an internal carotid artery web. 
  • Recurrent transient ischemic attacks and stroke in association with an internal carotid artery web. 
  • Regional cerebral blood flow estimated by 133-xenon inhalation. 
  • Regional cerebral blood flow, glucose metabolism, protein synthesis, serum protein extravasation, and content of biochemical substrates in stroke-prone spontaneously hypertensive rats. 
  • Relation between BMI and diabetes mellitus and its complications among US older adults. 
  • Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators. 
  • Releasable vascular plasminogen activator and thrombotic strokes. 
  • Reliability of the Fugl-Meyer assessment of sensorimotor recovery following cerebrovascular accident. 
  • Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial. 
  • Reply: To PMID 24360877. 
  • Restorative neurology. Drugs and recovery following stroke. 
  • Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study. 
  • Retinal microvascular signs and cognitive impairment. 
  • Retinal microvascular signs and risk of stroke and stroke mortality. 
  • Retinal vein occlusion and vascular mortality: pooled data analysis of 2 population-based cohorts. 
  • Retrospective assessment of initial stroke severity with the Canadian Neurological Scale. 
  • Risk factor profile and management of cerebrovascular patients in the REACH Registry. 
  • Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I. 
  • Risk of cerebrovascular events in elderly patients after radiation therapy versus surgery for early-stage glottic cancer. 
  • Risk of late stroke and survival following carotid endarterectomy procedures for symptomatic patients. 
  • Role of routine transthoracic echocardiography in evaluation and management of stroke. 
  • Sample size calculations for clinical trials using the NIH Stroke Scale. 
  • Saphenous vein versus polytetrafluoroethylene carotid patch angioplasty. 
  • Secular trends in ischemic heart disease mortality: regional variation. 
  • Should we just let the anticoagulation service do it? The conundrum of anticoagulation for atrial fibrillation. 
  • Silent aspiration following stroke. 
  • Similar motor recovery of upper and lower extremities after stroke. 
  • Six-month outcomes for MRI-related vascular depression. 
  • Speech therapy for aphasic stroke patients. 
  • Statin therapy--Part II: Clinical considerations for cardiovascular disease. 
  • Statins after intracerebral hemorrhage: to treat or not to treat. 
  • Stroke and acute myocardial infarction in the thrombolytic era: clinical correlates and long-term prognosis. 
  • Stroke disability. 
  • Stroke due to recurrent ipsilateral carotid artery dissection in a young adult. 
  • Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators. 
  • Stroke in young black patients. Risk factors, subtypes, and prognosis. 
  • Stroke prevention guidelines. 
  • Stroke prevention: the emerging strategies. 
  • Stroke with negative brain magnetic resonance imaging. 
  • Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. 
  • Substance abuse and cerebral blood flow. 
  • Sumatriptan-induced stroke in sagittal sinus thrombosis. 
  • Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. 
  • Surgical management of carotid artery atherosclerotic disease. 
  • Survival and outcome after endotracheal intubation for acute stroke. 
  • Sydenham Society: racial variations in carotid endarterectomy. 
  • Systematic review of CT and MR perfusion imaging for assessment of acute cerebrovascular disease. 
  • Systemic associations of retinal microvascular signs: a review of recent population-based studies. 
  • T2 hyperintensity of medial lemniscus: higher threshold application to ROI measurements is more accurate in predicting small vessel disease. 
  • TIA, stroke, and the bicuspid aortic valve. 
  • Temporal trends in U. S. multiple cause of death mortality data: 1968 to 1977. 
  • The American Heart Association Stroke Outcome Classification. 
  • The American Heart Association Stroke Outcome Classification: executive summary. 
  • The NeuroAiD II (MLC901) in vascular cognitive impairment study (NEURITES). 
  • The Stroke P.O.R.T.: secondary and tertiary prevention of ischemic stroke. Stroke Prevention Patient Outcomes Research Team. 
  • The Stroke Prevention Patient Outcomes Research Team. Goals and methods. 
  • The Stroke Prevention Policy Model: linking evidence and clinical decisions. 
  • The Vascular Impairment of Cognition Classification Consensus Study. 
  • The distribution of cerebrovascular amyloid in Alzheimer's disease varies with ApoE genotype. 
  • The dynamics of dimensions of age-related disability 1982 to 1994 in the U.S. elderly population. 
  • The impact of coronary artery disease on carotid endarterectomy. 
  • The importance of family history in cerebrovascular disease. 
  • The rational clinical examination. Clinical assessment of stroke. 
  • The risk of radiation-induced cerebrovascular disease in Chernobyl emergency workers. 
  • The risk of stroke after thrombolytic therapy. 
  • The significance of intraocular hemorrhages due to subarachnoid hemorrhage. 
  • The spectrum of brain MR abnormalities in sickle-cell disease: a report from the Cooperative Study of Sickle Cell Disease. 
  • The value of stroke prevention and treatment. 
  • Theories explaining racial differences in the utilization of diagnostic and therapeutic procedures for cerebrovascular disease. 
  • Therapy for granulomatous angiitis. 
  • Therapy of seizures associated with stroke. 
  • Threshold relationship between cerebral blood flow, glucose utilization, and energy metabolites during development of stroke in gerbils. 
  • Thrombolysis for stroke: pushed out of the window? 
  • Thrombolytic therapy for elderly patients. 
  • Thrombotic and cardiovascular complications related to nonionic contrast media during cardiac catheterization: analysis of 8,517 patients. 
  • Tissue plasminogen activator for acute ischemic stroke. 
  • Toward a new frontier in cardiac surgery. 
  • Transesophageal echocardiography in diagnosing cardioembolic stroke. 
  • Trials of streptokinase in stroke depend on early, accurate diagnosis. 
  • Two surgeons four-hand microneurosurgery with universal holder system: technical note. 
  • US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke. Carotid endarterectomy. 
  • US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic Stroke. Medical therapy in patients with carotid artery stenosis. 
  • US national survey of physician practices for the secondary and tertiary prevention of ischemic stroke. Design, service availability, and common practices. 
  • Unilateral asterixis: motor integrative dysfunction in focal vascular disease. 
  • Unilateral neurogenic pruritus following stroke. 
  • Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry. 
  • Use of common antiplatelet drugs for vascular diseases. 
  • Utility of postmortem magnetic resonance imaging in clinical neuropathology. 
  • Utility of transcranial Doppler ultrasound for the integrative assessment of cerebrovascular function. 
  • Validation of the Total Cerebrovascular Disease Burden Scale in a Community Sample. 
  • Vascular depression consensus report - a critical update. 
  • Vascular depression prevalence and epidemiology in the United States. 
  • Vascular nutritional correlates of late-life depression. 
  • Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. 
  • Ventilatory management in critical neurologic illness. 
  • Vertical gaze paralysis and intermittent unresponsiveness in a patient with a thalamomesencephalic stroke. 
  • What are the causes of late-life depression? 
  • What role do neurologists play in determining the costs and outcomes of stroke patients? 
  • When and how to study the carotid arteries. 
  • Worse blood pressure control in patients with cerebrovascular or peripheral arterial disease compared with coronary artery disease. 
  • Worse outcomes for patients undergoing brain tumor and cerebrovascular procedures following the ACGME resident duty-hour restrictions. 
  • [Neurology and cardiology: points of contact]. 
• 

  Keywords of People

  • Alexander, John Hunter Peel, Professor of Medicine, Medicine, Cardiology
  • Doraiswamy, P. Murali, Professor of Psychiatry and Behavioral Sciences, Duke Science & Society
  • James, Michael Lucas, Associate Professor of Anesthesiology, Anesthesiology, Neuroanesthesia
  • Laskowitz, Daniel Todd, Professor of Neurology, Duke Innovation & Entrepreneurship
  • McConnell, Eleanor Schildwachter, Associate Professor in the School of Nursing, with tenure, School of Nursing
  • Muir, Kelly Walton, Associate Professor of Ophthalmology, Ophthalmology, Glaucoma
  • O'Connor, Christopher Michael, Richard Sean Stack, M.D. / Guidant Foundation Professor of Cardiology, Medicine, Clinical Pharmacology
  • Reed, Shelby Derene, Professor in Population Health Sciences, Duke Science & Society
  • Sampson, John Howard, Robert H., M.D. and Gloria Wilkins Professor of Neurosurgery, in the School of Medicine, Immunology
  • Swaminathan, Madhav, Professor of Anesthesiology, Anesthesiology, Cardiothoracic
  • Warner, David Samuel, Distinguished Professor of Anesthesiology, in the School of Medicine, Neurobiology